Kronos Bio, Inc. Net Change in Cash
Kronos Bio, Inc. reported Net Change in Cash of $7.01 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2025-05-08
- Kronos Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $7.01M.
- Kronos Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$18.13M.
- Kronos Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$12.30M.
- Kronos Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$49.29M.
- Kronos Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $20.25M.
- Kronos Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$11.65M.
- Kronos Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$122.30M.
- Kronos Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was -$49.74M, a 122.87% decline from fiscal 2020.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2025-03-31 | $7.01M 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $20.25M 10-K · filed 2025-03-18 | |||
| 2024-09-30 | $10.64M 10-Q · filed 2024-11-13 | |||
| 2024-06-30 | $5.88M 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | -$18.13M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$11.65M 10-K · filed 2025-03-18 | |||
| 2023-09-30 | -$18.37M 10-Q · filed 2024-11-13 | |||
| 2023-06-30 | -$31.58M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | -$12.30M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$122.30M 10-K · filed 2024-03-21 | |||
| 2022-09-30 | -$130.79M 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | -$112.13M 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | -$49.29M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | -$49.74M 10-K · filed 2023-03-15 | |||
| 2021-09-30 | -$31.02M 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | -$62.35M 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | -$106.56M 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $217.47M 10-K · filed 2022-02-24 | |||
| 2020-09-30 | $125.65M 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $7.42M 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | -$1.74M 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | $22.34M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $92.51M 10-Q · filed 2020-11-18 | |||
| 2018-12-31 | $8.70M 10-K · filed 2021-03-23 |